Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Matrix Biol ; 47: 34-43, 2015 Sep.
Article in English | MEDLINE | ID: mdl-25957949

ABSTRACT

The ADAMTS (a disintegrin-like and metalloproteinase domain with thrombospondin-type 1 motifs) protein superfamily includes 19 secreted metalloproteases and 7 secreted ADAMTS-like (ADAMTSL) glycoproteins. The possibility of functional linkage between ADAMTS proteins and fibrillin microfibrils was first revealed by a human genetic consilience, in which mutations in ADAMTS10, ADAMTS17, ADAMTSL2 and ADAMTSL4 were found to phenocopy rare genetic disorders caused by mutations affecting fibrillin-1 (FBN1), the major microfibril component in adults. The manifestations of these ADAMTS gene disorders in humans and animals suggested that they participated in the structural and regulatory roles of microfibrils. Whereas two such disorders, Weill-Marchesani syndrome 1 and Weill-Marchesani-like syndrome involve proteases (ADAMTS10 and ADAMTS17, respectively), geleophysic dysplasia and isolated ectopia lentis in humans involve ADAMTSL2 and ADAMTSL4, respectively, which are not proteases. In addition to broadly similar dysmorphology, individuals affected by Weill-Marchesani syndrome 1, Weill-Marchesani-like syndrome or geleophysic dysplasia each show characteristic anomalies suggesting molecule-, tissue-, or context-specific functions for the respective ADAMTS proteins. Ectopia lentis occurs in each of these conditions except geleophysic dysplasia, and is due to a defect in the ciliary zonule, which is predominantly composed of FBN1 microfibrils. Together, this strongly suggests that ADAMTS proteins are involved either in microfibril assembly, stability, and anchorage, or the formation of function-specific supramolecular networks having microfibrils as their foundation. Here, the genetics and molecular biology of this subset of ADAMTS proteins is discussed from the perspective of how they might contribute to fully functional or function-specific microfibrils.


Subject(s)
ADAM Proteins/physiology , Microfibrils/enzymology , Animals , Bone Diseases, Developmental/enzymology , Bone Diseases, Developmental/genetics , Ectopia Lentis/enzymology , Ectopia Lentis/genetics , Fibrillin-1 , Fibrillins , Humans , Limb Deformities, Congenital/enzymology , Limb Deformities, Congenital/genetics , Marfan Syndrome/enzymology , Marfan Syndrome/genetics , Microfibrils/metabolism , Microfilament Proteins/physiology
2.
Am J Hum Genet ; 94(5): 755-9, 2014 May 01.
Article in English | MEDLINE | ID: mdl-24768550

ABSTRACT

We have previously described a syndrome characterized by facial dysmorphism, lens dislocation, anterior-segment abnormalities, and spontaneous filtering blebs (FDLAB, or Traboulsi syndrome). In view of the consanguineous nature of the affected families and the likely autosomal-recessive inheritance pattern of this syndrome, we undertook autozygosity mapping and whole-exome sequencing to identify ASPH as the disease locus, in which we identified two homozygous mutations. ASPH encodes aspartyl/asparaginyl ß-hydroxylase (ASPH), which has been found to hydroxylate aspartic acid and asparagine residues on epidermal growth factor (EGF)-domain-containing proteins. The truncating and missense mutations we identified are predicted to severely impair the enzymatic function of ASPH, which suggests a possible link to other forms of ectopia lentis given that many of the genes implicated in this phenotype encode proteins that harbor EGF domains. Developmental analysis of Asph revealed an expression pattern consistent with the proposed link to the human syndrome. Indeed, Asph-knockout mice had a foreshortened snout, which corresponds to the facial abnormalities in individuals with Traboulsi syndrome. These data support a genetic basis for a syndromic form of ectopia lentis and the role of aspartyl hydroxylation in human development.


Subject(s)
Anterior Eye Segment/abnormalities , Calcium-Binding Proteins/genetics , Craniofacial Abnormalities/genetics , Ectopia Lentis/genetics , Iris/abnormalities , Membrane Proteins/genetics , Mixed Function Oxygenases/genetics , Muscle Proteins/genetics , Amino Acid Sequence , Animals , Anterior Eye Segment/enzymology , Craniofacial Abnormalities/enzymology , DNA Mutational Analysis , Ectopia Lentis/enzymology , Epidermal Growth Factor/chemistry , Exome/genetics , Female , Humans , Iris/enzymology , Mice , Mice, Knockout , Molecular Sequence Data , Pedigree , Protein Structure, Tertiary/genetics , Syndrome , Young Adult
3.
Int Ophthalmol ; 31(3): 227-32, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21626167

ABSTRACT

To report a case of late diagnosis of a classical familial homocystinuria based on an ophthalmologic examination. A 35-year-old male with Marfan-like phenotype complained of a progressive increase of myopia during the previous 2 years. Ophthalmologic exploration showed a bilateral subluxation of the lens with inferior and nasal displacement. Biochemical study detected a profile of increased amino acid levels (homocysteinemia) consistent with suspected homocystinuria. Vascular and skeletal studies ruled out Marfan syndrome. Response to treatment demonstrated B(6)-non-responsive homocystinuria. Molecular study showed compound heterozygous T353 N and D444 N mutations of the cystathionine beta-synthase (CBS) gene, and also a C667T homozygous mutation of the methylenetetrahydrofolate-reductase (MTHFR) gene. Family study showed classical homocystinuria in his father and sister, although they did not present any systemic or ocular features of the disease. Homocystinuria is a metabolic disease usually presenting at an early age as vascular, skeletal and neuropsychiatric abnormalities, as well as ectopia lentis. Our case is atypical because of the absence of thromboembolism and the mild phenotype, in spite of being B(6)-non-responsive, and the association of a rare compound heterozygous mutation of the CBS gene and also an homozygous mutation of the MTHFR gene. It is necessary to rule out homocystinuria in patients with ectopia lentis, even in the absence of systemic symptoms.


Subject(s)
Ectopia Lentis/diagnosis , Homocystinuria/diagnosis , Adult , Cystathionine beta-Synthase/genetics , Cystathionine beta-Synthase/metabolism , DNA/genetics , Delayed Diagnosis , Diagnosis, Differential , Ectopia Lentis/enzymology , Ectopia Lentis/genetics , Genetic Testing/methods , Homocystinuria/enzymology , Homocystinuria/genetics , Humans , Male , Methylenetetrahydrofolate Reductase (NADPH2)/genetics , Methylenetetrahydrofolate Reductase (NADPH2)/metabolism , Mutation , Pedigree , Phenotype
SELECTION OF CITATIONS
SEARCH DETAIL
...